Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02362763
Other study ID # VESTIB-HMO-CTIL
Secondary ID
Status Completed
Phase N/A
First received January 28, 2015
Last updated February 9, 2015
Start date June 2006
Est. completion date June 2007

Study information

Verified date February 2015
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

Randomized controlled trial designed to determine whether acupuncture is an effective treatment for vestibulitis.


Description:

Patients were randomized to five acupuncture sessions designed to treat pain in the vulvar area (study group), or five acupuncture sessions designed for tranquility (controls). Participants and evaluating gynecologists were blinded to randomization. Participants were examined clinically before treatment and one month after completion of assigned treatment; at both visits they completed the Female Sexual Function Index (FSFI) questionnaire.

FSFI scores for pain during intercourse and total score were used to evaluate change. The examining gynecologist evaluated the degree of sensitivity to touch and the degree of local erythema. Response to treatment was evaluated for each group before and after treatment, and for study group compared to the control group.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date June 2007
Est. primary completion date June 2007
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Confirmed diagnosis of vestibulodynia

Exclusion Criteria:

- Pregnancy

- Patient who received other treatment for vestibulodynia in the month preceding.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Acupuncture
Patients randomized to the study group received five sessions of acupuncture in a series of points in the lower abdomen, lower back, hands, and feet. This combination of acupoints is believed to impact on the genital area, raise the pain threshold, and counteract inflammation. Control group patients received five sessions of acupuncture at acupoints that are believed to have no influence on the genital area, but are believed to have a general sedative effect.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Outcome

Type Measure Description Time frame Safety issue
Primary Female Sexual Function Index (FSFI) questionnaire 1 month after completion of the assigned treatment No
Secondary Clinical examination Visual presence or absence of vestibular erythema 1 month after completion of the assigned treatment No
See also
  Status Clinical Trial Phase
Completed NCT05478746 - Effects of Flourish HEC on Localized Provoked Vulvodynia N/A
Completed NCT01455350 - Efficacy of a Physiotherapy Treatment in Women Suffering From Provoked Vestibulodynia N/A
Completed NCT01304589 - Savella in Treatment for Provoked Vestibulodynia Phase 3
Completed NCT03844412 - Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Phase 2
Completed NCT02858219 - A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia Phase 3
Completed NCT01582373 - Pilot Study to Assess the Efficacy of Cognitive-behavioral Couple Therapy for Provoked Vestibulodynia N/A
Completed NCT05342402 - Feasibility Study for Provoked Vestibulodynia N/A
Recruiting NCT05805696 - Treatment and Mapping of Impostor Phenomenon N/A
Completed NCT01935063 - Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia N/A
Completed NCT02204319 - Cold Laser: A Modality to Promote Vulvar Healing and Pain Relief N/A
Completed NCT02858375 - Long-Term Assessment of Quality of Life and Effectiveness of Onabotulinumtoxina Injections in Provoked Vestibulodynia N/A
Withdrawn NCT01741948 - Hormonal Contraceptive Use and the Risk of Provoked Vestibulodynia N/A
Terminated NCT02854670 - A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia Phase 2/Phase 3
Recruiting NCT04613713 - Somatocognitive Therapy in Treatment of Provoked (Localized) Vestibulodynia - Randomized Clinical Trial (ProLoVe Study) N/A
Terminated NCT01295268 - Study of Emu Oil vs. Placebo for Vulvar Pain in Women. N/A
Terminated NCT03682601 - Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment Phase 2
Withdrawn NCT03390049 - Randomized CO2 vs Sham Laser Treatment of Provoked Vestibulodynia N/A
Completed NCT00496184 - Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis Phase 3
Completed NCT03431779 - Lipofilling as a Treatment for Vestibulodynia N/A